Is mupirocin (antibiotic ointment) okay to use for a patient with varicella and a secondary bacterial skin infection, such as impetigo, caused by Staphylococcus aureus or Streptococcus pyogenes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 13, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mupirocin for Secondary Bacterial Skin Infection in Varicella

Yes, mupirocin 2% ointment is appropriate and effective for treating secondary bacterial skin infections like impetigo complicating varicella, as it has excellent activity against both Staphylococcus aureus (including MRSA) and Streptococcus pyogenes, the primary pathogens in these infections. 1, 2, 3

FDA-Approved Indication

  • Mupirocin ointment 2% is FDA-approved specifically for topical treatment of impetigo caused by Staphylococcus aureus and Streptococcus pyogenes 3
  • This directly addresses the secondary bacterial infection complicating varicella 3

Application Protocol

  • Apply mupirocin 2% ointment directly to infected lesions 2-3 times daily 1, 2
  • Typical treatment duration is 5-10 days 2
  • Clinical response should be evident within 3-5 days 1

When Mupirocin Is Sufficient

  • Localized impetigo lesions without systemic signs of infection (no fever, limited number of lesions) 1, 2
  • Superficial secondary infections of varicella lesions with purulent crusting or honey-colored exudate 1, 3
  • Mild infections where the patient appears well and has no signs of deeper tissue involvement 1, 2

When to Escalate to Systemic Antibiotics

You must use systemic antibiotics instead of or in addition to mupirocin if: 1, 2

  • Fever or systemic signs of infection are present 1
  • Extensive cellulitis surrounds the infected varicella lesions 1
  • Multiple widespread lesions (>5-10 sites) are infected 1
  • No clinical improvement within 48-72 hours of topical therapy 1, 2
  • Deep tissue involvement or abscess formation is suspected 1, 2
  • Immunocompromised patient or other high-risk features 1

For these situations requiring systemic therapy, appropriate oral antibiotics include cephalexin, dicloxacillin, or clindamycin for MSSA, or trimethoprim-sulfamethoxazole, doxycycline (if age >8 years), or clindamycin for MRSA 1

Clinical Efficacy Evidence

  • Mupirocin achieves >90% bacterial eradication rates and clinical cure/improvement in impetigo 1, 4, 5
  • It demonstrates bactericidal activity against both S. aureus (including MRSA) and S. pyogenes at topically achieved concentrations 3, 4
  • Comparative studies show mupirocin is as effective as oral antibiotics (cephalexin, erythromycin) for localized impetigo 6

Important Caveats

  • Reassess at 48-72 hours: If infection is progressing despite mupirocin, assume treatment failure and switch to systemic antibiotics effective against MRSA 1, 2
  • Avoid prolonged use: Extended or indiscriminate use promotes resistance development 2
  • Not for extensive disease: Mupirocin is inappropriate when systemic therapy is clearly indicated 2, 3
  • Drainage required for abscesses: If any varicella lesions have progressed to true abscesses, incision and drainage is the primary treatment, with antibiotics as adjunctive therapy 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Mupirocin for Staph Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Overview of the role of mupirocin.

The Journal of hospital infection, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.